The global healthcare sector is currently undergoing a paradigm shift in how Healthcare-Associated Infections (HAIs) are managed. As a premier manufacturer from China, Hebei ROA Medicare Co., Ltd. recognizes that infection control is no longer a peripheral concern but the central pillar of modern clinical safety. From the implementation of Sterile Barrier Systems (SBS) to advanced antimicrobial chemical agents, the industry is moving toward high-precision, zero-tolerance environments.
The global infection control market is projected to reach USD 52.4 billion by 2030, driven by an aging global population and stringent regulatory frameworks such as EU MDR and US FDA 510(k) clearances.
Recent global health crises have permanently elevated the baseline for personal protective equipment (PPE) and surgical drapes, requiring higher barrier levels (AAMI Level 3 & 4) across all clinical tiers.
Modern procurement strategies now prioritize "Green Sterilization." We are pioneering the use of biodegradable non-wovens and recyclable PE films to reduce the carbon footprint of disposable medical waste.
Health, Trust & Innovation. Founded with a strong commitment to the healthcare industry, Hebei ROA Medicare Co., Ltd. has been dedicated to providing high-quality medical and healthcare products to customers worldwide. Over the years, we have consistently upheld the belief that “Health, Trust, and Innovation are the foundation of every family and society.”
The name “ROA Medicare” represents responsibility, professionalism, and care for human health. Our logo, combining blue and green, symbolizes the synergy between precision safety and vital healing. We believe that healthcare is not only about products, but also about trust, safety, and long-term commitment to customers and patients worldwide.
Infection control is transitioning from passive protection (barriers) to active intervention. At Hebei ROA Medicare, our R&D pipeline focuses on three critical technology routes:
Developing catheters and surfaces with intrinsic silver-ion or copper-based antimicrobial properties to disrupt biofilm formation on long-term medical implants.
Enhancing Type 4 and Type 6 chemical indicators with digital-read capabilities, ensuring that every sterilization cycle in a hospital is verified with AI-driven monitoring.
As robotic surgery (e.g., Da Vinci systems) becomes standard, we are engineering specialized drapes that allow full range of motion while maintaining absolute sterile integrity for articulated arms.
Our solutions are engineered for diverse, high-stakes environments:
Exporting Countries
Quality Certified
Cleanroom Grade
Technical Support
ROA Medicare continuously invests in supply chain optimization and modern production technologies to ensure zero-defect manufacturing.
Water Purifying System
Ensuring medical-grade purity for all chemical production.
Precision Mixing
Automated blending for consistent disinfectant formulations.
Aseptic Filling
High-speed filling lines in Class 100,000 cleanrooms.
Automated Packing
Ensuring sterile barrier integrity during final packaging.
Smart Warehouse
GSP-compliant storage and logistics management.
Casting Tape Production
Advanced machinery for orthopedic rehabilitation supplies.
We provide comprehensive traceability for every batch. Unlike standard suppliers, we offer detailed technical data sheets (TDS) and validation reports that go beyond basic compliance, providing our clients with the necessary data to pass the most rigorous local health audits.
Our products are manufactured under ISO 13485:2016 quality management systems. Depending on the product line, we hold CE certification, FDA 510(k) clearances, and comply with EN 13795 standards for surgical drapes and gowns.
Yes. We specialize in the development of procedure-specific packs. Our engineering team can customize drape dimensions, aperture sizes, and material weight (GSM) to meet the specific needs of specialized surgical units like Neurosurgery or Ophthalmology.
We are actively transitioning our non-woven product lines to include recycled content and exploring bio-based polymers. Our goal is to maintain the highest sterile barrier protection while reducing the long-term environmental impact of medical waste.